The Committee is requesting actors in the health care sector to
submit "white papers" in PDF or Microsoft Word format
that address potential improvements in the following
Program Integrity Reforms to Protect Beneficiaries and Prevent
Fraud and Abuse
Payment Integrity Reforms to Ensure Accuracy, Efficiency and
Fraud and Abuse Enforcement Reforms to Ensure Tougher Penalties
Against Those Who Commit Fraud
The white papers should be submitted via email by June 29th to
The Committee members plan to have their staff review the white
papers and then compile a summary document highlighting key
proposals later in 2012.
This letter is the most recent instance where the government has
sought the expertise of the private sector in addressing fraud,
waste, and abuse. Another example came to light in February 2012,
when HHS-OIG issued its report related to the Pharmacy Compliance
Roundtable, where it convened compliance professionals in the
pharmaceutical industry. There, the private sector players
discussed their experiences with Corporate Integrity Agreements
(CIAs) and other compliance efforts initiated by the government
with HHS-OIG representatives. Prevention is becoming the new focus
of fraud-fighting efforts, and the government needs private sector
cooperation to achieve its goals in this area.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
My New Year's resolutions will likely be broken early and often in 2016. My consequences are mostly nonmonetary: a few more pounds, a little less savings, and not winning the triathlon in my age group.
Employers with more than 50 employees are usually aware that the Family Medical Leave Act (FMLA) may apply to their business and their workers. That law, which provides for protected leave for employees in certain situations and various amounts, can sound simple but is very complex in its details.
For the second time in less than a year, the U.S. Department of Justice (DOJ) has filed an antitrust complaint against hospital systems that agreed to not advertise on billboards or in print in each other's home county.
Arguing that the current state of the law weakens the patent system and poses a danger to life science innovators, biotechnology company, Sequenom, Inc., has filed a writ of certiorari with the U.S. Supreme Court, asking the Court to provide clarification regarding the limits of 35 U.S.C. § 101 as it relates to patent eligibility of diagnostic tests.